Dr. Rubsamen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1601 Ygnacio Valley Rd
Walnut Creek, CA 94598Phone+1 925-939-3000Fax+1 925-947-5286
Education & Training
- Massachusetts General HospitalResidency, Anesthesiology, 1986 - 1989
- California Pacific Medical CenterInternship, Internal Medicine, 1985 - 1986
- Stanford University School of MedicineClass of 1985
Certifications & Licensure
- MI State Medical License 2017 - 2027
- OH State Medical License 2020 - 2026
- WA State Medical License 2019 - 2026
- CA State Medical License 1986 - 2025
- MA State Medical License 1989 - 2025
- MD State Medical License 2024 - 2025
- ND State Medical License 2020 - 2025
- American Board of Anesthesiology Anesthesiology
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsSurvivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary S...Scott R Burkholz, Charles V Herst, Richard T Carback, Paul E Harris, Reid M Rubsamen
Vaccines. 2023-03-13 - 19 citationsAn Approach for a Synthetic CTL Vaccine Design against Zika Flavivirus Using Class I and Class II Epitopes Identified by Computer Modeling.Edecio Cunha-Neto, Daniela Santoro Rosa, Paul L. Harris, Tim Olson, Alex Morrow
Frontiers in Immunology. 2017-06-09 - 29 citationsA Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus MacaquesPaul L. Harris, Trevor Brasel, Christopher Massey, C. V. Herst, Scott Burkholz
Vaccines. 2021-05-18
Press Mentions
- Respada Global Healthcare Summit 2020 Convenes World Leaders in Healthtech to Discuss COVID-19 ChallengesAugust 11th, 2020
- University of Pittsburgh – PittCoVaccMay 18th, 2020
- Biotech Flow Pharma, Inc. Announces U.S. Department of Defense Chemical and Biological Defense (CBD) Small Business Technology Transfer Program (STTR) Follow-on AwardMay 13th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: